IRIS Accounts Production v25.1.0.734 14142941 Board of Directors Board of Directors Board of Directors 1.6.23 31.5.24 31.5.24 false true false false true false Ordinary 11.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh141429412023-05-31141429412024-05-31141429412023-06-012024-05-31141429412022-05-30141429412022-05-312023-05-31141429412023-05-3114142941ns15:EnglandWales2023-06-012024-05-3114142941ns14:PoundSterling2023-06-012024-05-3114142941ns10:Director12023-06-012024-05-3114142941ns10:Director22023-06-012024-05-3114142941ns10:Director32023-06-012024-05-3114142941ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3114142941ns10:SmallEntities2023-06-012024-05-3114142941ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3114142941ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3114142941ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3114142941ns10:FullAccounts2023-06-012024-05-3114142941ns10:OrdinaryShareClass12023-06-012024-05-3114142941ns10:CompanySecretary12023-06-012024-05-3114142941ns10:RegisteredOffice2023-06-012024-05-3114142941ns5:CurrentFinancialInstruments2024-05-3114142941ns5:CurrentFinancialInstruments2023-05-3114142941ns5:ShareCapital2024-05-3114142941ns5:ShareCapital2023-05-3114142941ns5:RetainedEarningsAccumulatedLosses2024-05-3114142941ns5:RetainedEarningsAccumulatedLosses2023-05-3114142941ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3114142941ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3114142941ns10:OrdinaryShareClass12024-05-3114142941ns5:RetainedEarningsAccumulatedLosses2023-05-3114142941ns5:RetainedEarningsAccumulatedLosses2023-06-012024-05-31
REGISTERED NUMBER: 14142941 (England and Wales)















MEDIPOINT UK LTD

Unaudited Financial Statements for the Year Ended 31 May 2024






MEDIPOINT UK LTD (REGISTERED NUMBER: 14142941)






Contents of the Financial Statements
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDIPOINT UK LTD

Company Information
FOR THE YEAR ENDED 31 MAY 2024







DIRECTORS: S Chopra
B U Gor
Mrs S G Khanna





SECRETARY: Mrs S G Khanna





REGISTERED OFFICE: 30 Hatfeild Mead
Modern
SM4 5PE





REGISTERED NUMBER: 14142941 (England and Wales)





ACCOUNTANTS: Millennium Professional Services (UK) Limited
Lotus House
227 Preston Road
Wembley
Middlesex
HA9 8NF

MEDIPOINT UK LTD (REGISTERED NUMBER: 14142941)

Balance Sheet
31 MAY 2024

31.5.24 31.5.23
Notes £    £   
CURRENT ASSETS
Stocks 4 73,241 52,176
Debtors 5 660 12,481
Cash at bank 26,520 2,871
100,421 67,528
CREDITORS
Amounts falling due within one year 6 117,042 80,509
NET CURRENT LIABILITIES (16,621 ) (12,981 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(16,621

)

(12,981

)

CAPITAL AND RESERVES
Called up share capital 7 99 99
Retained earnings 8 (16,720 ) (13,080 )
SHAREHOLDERS' FUNDS (16,621 ) (12,981 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 April 2025 and were signed on its behalf by:




S Chopra - Director Mrs S G Khanna - Director




B U Gor - Director


MEDIPOINT UK LTD (REGISTERED NUMBER: 14142941)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

Medipoint UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

MEDIPOINT UK LTD (REGISTERED NUMBER: 14142941)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MAY 2024

4. STOCKS
31.5.24 31.5.23
£    £   
Stocks 73,241 52,176

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Directors' current accounts 33 66
VAT 627 12,415
660 12,481

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade creditors 2,130 19,807
Amounts owed to associates 76,100 40,000
Other creditors 10,000 -
Directors' current accounts 28,812 19,952
Accrued expenses - 750
117,042 80,509

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.24 31.5.23
value: £    £   
99 Ordinary 11 99 99

8. RESERVES
Retained
earnings
£   

At 1 June 2023 (13,080 )
Deficit for the year (3,640 )
At 31 May 2024 (16,720 )